Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 47, Issue 4, April 2022, Pages 233-301
 
MONOGRAPHS
 
  
 Ciltacabtagene autoleucel.
CAR-T therapy targeting B-cell maturation antigen (BCMA), Treatment of multiple myeloma.
Lee, S., Cowan, A.J.
Drugs Fut 2022, 47(4): 233
Summary | Full Text: PDF 
 
  
  
 Donanemab.
Monoclonal antibody targeting N3pG Β-amyloid, Treatment of early Alzheimer's disease.
Buxbaum, J.N.
Drugs Fut 2022, 47(4): 239
Summary | Full Text: PDF 
 
  
  
 Navtemadlin.
MDM2–p53 interaction inhibitor, Treatment of cancer.
Price, S., Al-Bahou, A.
Drugs Fut 2022, 47(4): 247
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the Move.
Fernandez Bertolin, L.
Drugs Fut 2022, 47(4): 261
Full Text: PDF 
 
  
  
 NME Digest.
Bofill, X., Cole, P., Fernandez-Forner, D.
Drugs Fut 2022, 47(4): 271
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 San Antonio Breast Cancer Symposium 2021 – 44th Annual Meeting. Virtual/San Antonio – December 7-10, 2021.
Sudha, P.
Drugs Fut 2022, 47(4): 281
Summary | Full Text: PDF 
 
  
  
 American Society of Hematology – 63rd Annual Meeting and Exposition. Virtual/Atlanta – December 11-14, 2021.
Walker, G., Sridevi, M., Reddy Challapally, A.
Drugs Fut 2022, 47(4): 285
Summary | Full Text: PDF 
 
  
  
 The 40th Annual J.P. Morgan Healthcare Conference. Virtual – January 10-13, 2022.
Sudha, P., Polychrones, J., Komlos, D.
Drugs Fut 2022, 47(4): 291
Summary | Full Text: PDF 
 
  
 
  



© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences